ImaginAb’s Post

Interesting article about using CD8 ImmunoPET to image and provide in vivo mapping of the CD8+ cellular response in early phase #clinicaltrials !

Conventional ADME study methods in vitro 2D cell culture and in vivo animal models are limited by poor clinical translatability, which impacts the drug candidate selection process and dosage figures. In this American Pharmaceutical Review article, our Lead Scientist, Dr Yassen Abbas, talks about emerging complementary technologies, such as organ-on-a-chip (OOC), that allow for human-relevant in vitro preclinical studies. Additionally, he discusses how OOC technology can be applied to determine human bioavailability, inform dosing regimens, reduce side effects, and potentially recover flawed therapeutic candidates. Read the full article here: https://bit.ly/48OLe5U #OrganOnAChip #ADME #Bioavailability #Innovation

Struggling with interaction analysis across your workflows? If so, our upcoming masterclass might help! ⬇️ Learn from our experts how Isothermal Titration Calorimetry (ITC) and Grating Coupled Interferometry (GCI) are complementary and orthogonal techniques in early-stage drug discovery. We’ll also explore how these technologies can be applied to complex targets and interactions in various applications. Here’s what else we’ll cover: - Hit finding: How to establish a fragment screen using GCI - Hit identification: Tips, tricks, and considerations - Hit validation: How to orthogonally validate hits using ITC If you work in early-stage drug discovery or have a specific interest in small molecule/fragment screening, this is the webinar for you. We’d love to see you there 👋 Register for free 🔗 https://bit.ly/3VeKDXg 🗓️ June 18 🕕 18:00 CET, 12:00 EST, 09:00 PST 💻 Online ⏳ 45 mins #drugdiscovery #pharmaceuticals #fbdd

Join us at MEDICRES AI 2024 for an insightful session with Erdem Büyükbingöl. 'NEW DRUG DISCOVERY WITH BIG PHARMA AND UNIVERSITY STRATEGIC INTELLIGENCE' will delve into the pioneering collaboration between academia and the pharmaceutical industry, highlighting the role of strategic intelligence in accelerating the development of groundbreaking medications. This presentation is a must-see for anyone interested in the future of pharmacology and the innovative strategies driving forward drug discovery. Discover how these partnerships are shaping the next generation of medical treatments. Join Us Now: www.medicres.ai #MedicReSAI #medicresai2024 #drugdiscovery #artificialintelligence

Join us at MEDICRES AI 2024 for an insightful session with Erdem Büyükbingöl. 'NEW DRUG DISCOVERY WITH BIG PHARMA AND UNIVERSITY STRATEGIC INTELLIGENCE' will delve into the pioneering collaboration between academia and the pharmaceutical industry, highlighting the role of strategic intelligence in accelerating the development of groundbreaking medications. This presentation is a must-see for anyone interested in the future of pharmacology and the innovative strategies driving forward drug discovery. Discover how these partnerships are shaping the next generation of medical treatments. Join Us Now: www.medicres.ai #MedicReSAI #medicresai2024 #drugdiscovery #artificialintelligence

Discover how AI-powered #MedicalImaging solutions are revolutionizing #Pharmaceutical R&D! From molecule identification to clinical trial recruitment, join us at #GTC24 as we delve into the cutting-edge methods and infrastructure used at J&J Innovative Medicine. Learn how robust models in histopathology are accelerating #drugdiscovery.

Discover how AI-powered #MedicalImaging solutions are revolutionizing #Pharmaceutical R&D! From molecule identification to clinical trial recruitment, join us at #GTC24 as we delve into the cutting-edge methods and infrastructure used at J&J Innovative Medicine. Learn how robust models in histopathology are accelerating #drugdiscovery.

Discover how AI-powered #MedicalImaging solutions are revolutionizing #Pharmaceutical R&D! From molecule identification to clinical trial recruitment, join us at #GTC24 as we delve into the cutting-edge methods and infrastructure used at J&J Innovative Medicine. Learn how robust models in histopathology are accelerating #drugdiscovery.

Discover how AI-powered #MedicalImaging solutions are revolutionizing #Pharmaceutical R&D! From molecule identification to clinical trial recruitment, join us at #GTC24 as we delve into the cutting-edge methods and infrastructure used at J&J Innovative Medicine. Learn how robust models in histopathology are accelerating #drugdiscovery.

Scientists at Klick Applied Sciences have created an artificial intelligence framework that can rapidly identify new use cases for existing therapeutics, according to findings presented at the NeurIPS conference that could greatly improve the drug repurposing process and transform the pharmaceutical industry. Read more below: #ai #therapeutics #drugrepurposing